The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I and pharmacokinetic study of a weekly dosing schedule of paclitaxel injection concentrate for nano-dispersion (PICN) in patients with advanced solid tumors.
Wen Wee Ma
Research Funding - Sun Pharma
Jennifer Robinson Diamond
No relevant relationships to disclose
Grace K. Dy
No relevant relationships to disclose
Wells A. Messersmith
No relevant relationships to disclose
Yujie Zhao
No relevant relationships to disclose
Lynne A. Bui
Consultant or Advisory Role - Sun Pharma
Gerald J. Fetterly
No relevant relationships to disclose
Ronald Harning
Employment or Leadership Position - Sun Pharma
Henry Raphael Wolfe
Employment or Leadership Position - Sun Pharma
Pepi Pencheva
Consultant or Advisory Role - Sun Pharma
Shravanti Bhowmik
Employment or Leadership Position - Sun Pharma
Ganesh Divekar
Employment or Leadership Position - Sun Pharma
Narendra B. Lakkad
Employment or Leadership Position - Sun Pharma
Ajay J. Khopade
Employment or Leadership Position - Sun Pharma
Ann Marie DiRaddo
No relevant relationships to disclose
S. Gail Eckhardt
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose
Antonio Jimeno
Research Funding - Sun Pharma